Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT05233111

Brief Prolonged Exposure Therapy Versus Clinical Standard to Reduce Posttraumatic Stress Post Spinal Cord Injury

Prevention of Posttraumatic Stress: A RCT of Modified Brief Prolonged Exposure Therapy (Brief PE) During Inpatient Rehabilitation Post Spinal Cord Injury (SCI)

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Baylor Research Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will examine the use brief prolonged exposure (Brief PE) therapy compared to standard clinical care to reduce posttraumatic distress among people who have had a spinal cord injury and are receiving rehabilitation in an inpatient setting.

Detailed description

This is a prospective randomized controlled trial examining the efficacy of brief Prolonged Exposure Therapy (Brief PE) delivered in an inpatient rehabilitation setting post-SCI to reduce PTSD symptoms. The overall goal of this project is to test a Brief PE (three 60-minute sessions) to reduce psychological distress after SCI and to mitigate long-term post-SCI distress including PTSD as well as secondary health outcomes (including depression and general anxiety) at 1, 3, and 6 months from baseline. The intervention group (Brief PE) will be compared to standard clinical care with treatment as usual (TAU).

Conditions

Interventions

TypeNameDescription
BEHAVIORALBrief Prolonged Exposure TherapyBrief PE will include 3 therapy sessions, each lasting approximately 60 minutes.
BEHAVIORALTreatment as UsualThis may include an evaluation by a licensed psychologist and continued follow-up psychotherapy as needed. Treatment as usual participants will have follow-up assessments at 1, 3, and 6 months.

Timeline

Start date
2022-02-07
Primary completion
2026-08-01
Completion
2026-08-01
First posted
2022-02-10
Last updated
2026-01-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05233111. Inclusion in this directory is not an endorsement.